This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Dentin Sensitivity
and you are
-
The phase for this study is not defined.
Show me locations

The purpose

Aim: to investigate the clinical effectiveness over 12 weeks of three different biomaterials, nano-hydroxyapatite based, in the therapy of the dental sensitivity. Methods: The study is designed as a randomized clinical trial comparing: 1) Cavex Bite&White ExSense, 2) Teethmate™ Desensitizer , 3) Ghimas Dentin Desensitizer. The pain experience was generated by a cold stimulus directly to a sensitive tooth surface and assessed using the Visual Analogue Scale (VAS). The response was recorded before the application of the materials (PRE-1), immediately after (POST-1), at 1-week (POST-2), 4-weeks (POST-3) and 12-week controls (POST-4).

Provided treatments

  • Other: Cavex Bite&White ExSense
  • Other: Kuraray Teethmate™ Desensitizer
  • Other: Ghimas Dentin Desensitizer
Tris trial is registered with FDA with number: NCT02770573. The sponsor of the trial is Università degli Studi di Sassari and it is looking for 90 volunteers for the current phase.
Official trial title:
Long-term Response of Three Biomaterials Used as Desensitizer Agents Under Oral Environmental Exposure.